Advanced Neuroendocrine Neoplasm

1

Review clinical trials related to Advanced Neuroendocrine Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms

This is a multicenter, single-arm, two-part study designed to evaluate the safety and efficacy of Lutetium \[177Lu\] Oxyoctreotide Injection in patients with inoperable, locally advanced or metastatic, progressive, advanced somatostatin receptor (SSTR) positive neuroendocrine neoplasms (NEN) other than grade G1/G2 gastroenteropancreatic neuroendocrine tumors (GEP-NET) and Neuroendocrine Carcinoma(NEC).

Participants needed: 85
Trial details
Phase: Phase 2, Phase 3Age: 12+Biological sex: AllType: InterventionalSponsor: Sinotau Pharmaceutical GroupUpdated: Jul 17, 2026Locations: 1
Eligibility criteria

Subjects who have been fully informed of this study and have voluntarily signed... [+4]

Serum creatinine > 150 μmol/L (1.7 mg/dL) or creatinine clearance rate < 50 mL/m... [+24]